CTNNB1 and breast cancer: To test this hypothesis, we investigated the expression of DKK1 and beta-catenin in tumor specimens from 85 patients with breast cancer and the correlation between DKK1 and beta-catenin together with other clinical pathological features of prognosis in this study.